Cisneros VSL, García VC, Herrera CMA

Idioma: Español
Referencias bibliográficas: 26
Paginas: 86-91
Archivo PDF: 530.92 Kb.

RESUMEN

El linfoma no Hodgkin intraocular y del sistema nervioso central (SNC) son presentaciones poco usuales y en la mayoría de los casos se presentan en forma asociada. De acuerdo con la literatura, pocos se han manifestado con hipoglucemia y acidosis láctica. Es por eso que reportamos el caso de una paciente femenina de 49 años de edad, hospitalizada en el Servicio de Medicina Interna del Hospital Juárez de México, SS. Ingresó por ataque al estado general, alteraciones visuales, hipoglucemia y acidosis láctica refractaria a tratamiento. Se logró documentar linfoma no Hodgkin primario de ojo izquierdo. Falleció 24 horas después de haber iniciado quimioterapia.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. CHEST 2000; 117: 260-7.

2. Sillos EM, Sheenep JL, Burghen GA, Pui Ching-Hon, Behm FG, Sandlund JT. Lactic acidosis: a metabolic complication of hematologic malignancies. Cancer 2001; 92: 2237-46.

3. Field M, Block JB, Levin R, Rall DP. Significance of blood lactate elevations among patients with acute leukemia and other neoplastic proliferative disorders. Am J Med 1966; 40: 528-47.

4. Deyrin D, Balko Ch. Glucose-lactate inter-relations in man. NEJM 1972; 287(3): 132-7.

5. Goodgame J. Thomas, Pizzo Jr. Phillip, Brennan MF. Iatrogenic lactic acidosis. Cancer 1978; 42: 800-3.

6. Sans-Sabrafen J, Besses RC. Vives CJL, Castillo CR, Woessner CS. Linfoma no Hodgkin. Hematología clínica. Harcourt 2002: 439-84.

7. Cortina P, Navea A, Díaz M. Linfoma intraocular y otros tumores. http://www.oftalmo.com/sida/CAP49.HTM

8. Char DH, Ljung Britt-Marie, Miller T, Phillips T. Primary intraocular lymphoma (ocular reticulum cell sarcoma). Diagnosis and management. Ophthalmology 1988; 95: 625-30.

9. Whitcup SM, De Smet MD, Rubin BI, Palestine AG, Martin DF, Burnier MJr, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 1993; 100: 1399- 406.

10. López JS, Chan Chi-Chao, Burnier M, Rubin B, Nussenblatt RB. Immunohistochemistry findings in primary intraocular lymphoma. Am J Ophthalmology 1991; 112(4): 472-4.

11. A. Adán. Cirugía vitreorretiniana y uveítis. http:// www.oftalmored.com/vitreorretiniana/capitulo16.htm

12. Wilson DJ, Braziel R, Rosenbaum J. Intraocular lymphoma. Immunopathologic analysis of vitreous biopsy specimens. Arch Ophthalmol 1992; 110: 1455-8.

13. Char DH, Ljung Britt-Marie, Deschénes J, Miller TR. Intraocular lymphoma: immunological and cytological analysis. B J Ophthalmology 1988; 72: 905-11.

14. Giles FJ, Vose JM, Do Kim-Anh, Johnson MM, Manshouri T, Bociek G, et al. Circulating CD20 and CD52 in patients with non-Hodgkin’s lymphoma or Hodgkin’s disease. B J Haematology 2003; 123: 850-7.

15. Dávila RM. Biopia por aspiración con aguja fina de tumores intraoculares. conganat.uninet.edu/IVCVHAP/CONFERENCIAS/ Davila

16. Finger P, Saornil M, Vecilla G. Linfoma introocular. Eye cancer network. pfinger@eyecancer.com.

17. Hollender A, Kvaloy S, Nome O, Skovlund E, Lote K, Holte H. Central nervous system involvement following diagnosis of non-Hodgkin’s lymphoma: a risk model. Annals of Oncology 2002; 13: 1099-107.

18. Balzarotti M, Spina M, Sarina B, Magagnoli M, Castagna L, Milan I, et al. Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide. Annals of Oncology 2002; 13: 1341-6.

19. Emmanouilides C, Territo M, Menco H, Patel R, Rosen P. Mitoxantrone-cyclophosphamide-rituximab: an effective and safe combination for indolent NHL. Hematological Oncology 2003; 21: 99-108.

20. Martinelli G, Laszlo D, Bertolini F, Pastano R, MP, Calleri A, et al. Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non- Hodgkin’s lymphoma. BJ Haematology 2003; 123: 271-7.

21. Zelenetz AD, Hamlin P, Kewalramani T. Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non- Hodgkin’s lymphoma. Annals of Oncology 14 (Suppl. 1): i5- i10, 2003.

22. Di Comité G, Dagna L, Piatti PM, Monti LD, Tantardini F, Praderio L. Hypoglycaemia and lactic acidosis in a MALT non Hodgkin’s lymphoma. Leuk lymphoma 2002; 43(4): 1341-2.

23. Nadiminti Y, Wang JC, Chou Shyan-yih, Pineles E, Tobin MS. Lactic acidosis associated with Hodgkin’s disease. NEJM 1980; 303(1): 15-17.

24. Fields ALA, Wolman SL(+), Halperin ML. (+). Chronic lactic acidosis in a patient with cancer: therapy and metabolic consequences. Cancer 1981; 47: 2026-9.

25. Fraley DS, Adler Sh, Bruns FJ, Zett B. Stimulation of lactate production by administration of bicarbonate in a patient with a solid neoplasm and lactic acidosis. NEJM 1980; 6: 1100-2.

26. Knowles DM, Jakobiec FA, McNally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa orbit, conjunctiva, and eyelids: a prospective multiparametric analysis of 108 cases during 1977 to 1987. Human Pathology 1990; 21(9): 959-73.